Both in Surgical Instruments
DexCom vs Medline
Over the past year DXCM returned +27.7% and MDLN returned −17.3%; their daily moves had a correlation of 0.24.
DXCM +27.7% MDLN −17.3%Growth of $1, one year, split-adjusted
| Metric | DXCM | MDLN |
|---|---|---|
| Price | $83.94 | $33.93 |
| Market cap | $31.31B | $29.76B |
| Today | −0.97% | +0.88% |
| 1 month | −3.4% | −5.2% |
| 6 months | +41.1% | −25.1% |
| Year to date | +26.5% | −19.2% |
| 1 year | +44.2% | — |
| Revenue growth (YoY) | +11.2% | — |
| Gross margin | 64.3% | 28.8% |
| Net margin | 20.5% | 0.8% |
| P/E (TTM) | 31.6× | — |
| Price / sales | 6.1× | — |
| Net cash | $574.2M | -$9.90B |
| Dividend yield | — | — |
| Volatility (60d) | 29.1% | 35.8% |
| Short % of float | 4.2% | 13.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).